Save the date and stay tuned!

More information

If you wish to be notified when the registration opens, we are happy to add you to our mailing list. Please contact:

Balgrist University Hospital
Claudia Gasser-Fideeler
+41 44 386 38 32
Email

- Including Swiss Surgeons Sessions (featured by the Swiss Orthopaedic shoulder expert group)
- Reduced fee for Swiss Orthopaedic members

Faculty

Tjarco Alta, Amsterdam | Johannes Barth, Grenoble |Samy Bouaicha, Zurich | Patrick Denard, Medford | Florian Grubhofer, Zurich | Jay Keener, St. Louis | Laurent Lafosse, Annecy | Thibault Lafosse, Annecy | Philipp Moroder, Zurich | Patric Raiss, Munich | Markus Scheibel, Zurich | Olivier Verborgt, Bruxelles | Jon J.P. Warner, Boston | Jean-David Werthel, Paris | Members of the Swiss Orthopaedics shoulder expert group

Registration

Registration fee

Early bird fee until May 31st
CHF 400.-

Swiss Orthopaedics members
CHF 350.-

Registration

Venue

Balgrist University Hospital, Forchstrasse 340, 8008 Zurich, Switzerland

Download

Flyer (PDF)

Kontakt

Stefanie Pfister
Congress Coordinator
+41 44 386 38 33
Email

- Including Swiss Surgeons Sessions (featured by the Swiss Orthopaedic shoulder expert group)
- Reduced fee for Swiss Orthopaedic members

Faculty

Tjarco Alta, Amsterdam | Johannes Barth, Grenoble |Samy Bouaicha, Zurich | Patrick Denard, Medford | Florian Grubhofer, Zurich | Jay Keener, St. Louis | Laurent Lafosse, Annecy | Thibault Lafosse, Annecy | Philipp Moroder, Zurich | Patric Raiss, Munich | Markus Scheibel, Zurich | Olivier Verborgt, Bruxelles | Jon J.P. Warner, Boston | Jean-David Werthel, Paris | Members of the Swiss Orthopaedics shoulder expert group

Registration

Registration fee

Early bird fee until May 31st
CHF 400.-

Swiss Orthopaedics members
CHF 350.-

Registration

Venue

Balgrist University Hospital, Forchstrasse 340, 8008 Zurich, Switzerland

Download

Flyer (PDF)

Kontakt

Stefanie Pfister
Congress Coordinator
+41 44 386 38 33
Email

In the planned advanced course, nationally and internationally renowned instructors, speakers and tutors will provide you with the necessary knowledge and skills to consolidate and perfect ultrasound-guided regional anesthesia in the daily practice of anesthesiology.

Registration

Registration fee

CHF 450.-

Registration

Course language

German

Accreditation

SSAPM, SGUM POCUS certificate of competence

Event location

Balgrist University Hospital
Auditorium Christian Gerber and seminar rooms
Forchstrasse 340, 8008 Zurich
Directions

Program

Download the program (PDF)

Contact

Claudia Gasser-Fideeler
+41 44 386 38 32
E-Mail

Link to the study

Reference

Marth AA, Goller SS, Kajdi GW, Marcus RP, Sutter R. Photon-Counting Detector CT: Clinical Utility of Virtual Monoenergetic Imaging Combined With Tin Prefiltration to Reduce Metal Artifacts in the Postoperative Ankle. Investigative Radiology 2024 online before print

For further information please contact

Gregor Lüthy, Head of Communications
Balgrist University Hospital
+41 44 386 14 15
Email

When pain occurs due to infections following operations on the shoulder joint, acne bacteria play a part in over 60 % of cases. They are detected at the source of infection during the necessary follow-up operations. Thorough disinfection of the surgical site and antibiotic treatment are evidently unable to prevent their penetration.

However, if commercial acne cream is generously applied to the relevant shoulder every evening for a week before the operation, these acne bacteria no longer penetrate as far as the shoulder joint capsule. This was the finding of a recent study conducted among 60 patients at Balgrist University Hospital.

Two properties are critical for determining whether the acne bacteria can get as far as the joint capsule. Firstly, they primarily colonize sebaceous glands in the lower skin layer, especially around the hair root, and thus avoid surface skin disinfection. Secondly, they protect themselves with an antibiotic-resistant shell. “If the acne bacterium encapsulates itself to shield itself from antibiotics and thus reaches the shoulder joint capsule, it can infect the material inserted there, for example the prosthesis,” explained Dr. med. Ines Unterfrauner, first-time author of the studies. She added: “When cutting through the subcutaneous tissue during the operation, there is a risk that the bacterium gets inside the joint.”

The commercial acne cream selected for the study was proven to be effective because it contains two highly effective substances: the antibacterial substance benzoyl peroxide and the antifungal agent miconazole nitrate that, according to laboratory studies, also successfully eliminates antibiotic-resistant bacteria.

Sixty adult patients with an average age of 59 took part in the Balgrist study between November 2018 and May 2020. During the open shoulder operation, they first either received a prosthetic replacement joint or the joint was stabilized using the Latarjet procedure. Before the start of the study, the intended shoulder of all patients was examined for acne bacteria using a swab (sample 1). Half of the patients then applied Widmer Acne Creme Plus Widmer to the affected shoulder in the evening seven days before the procedure, while the other half did not. A further skin sample was taken from all patients in the operating theater before making the cut (sample 2). Samples of subcutaneous tissue (sample 3) and shoulder joint capsule (sample 4) were then taken during the operation. In 60 % of all patients, the shoulder was inhabited by acne bacteria prior to the start of the study (sample 1). Among these 60 %, the effectiveness of the acne cream could be seen before the procedure (sample 2). Here, the skin was free of acne bacteria in 10 of 18 patients. Among the subcutaneous samples, 17 of 18 patients were free of acne bacteria and, in particular, the joint capsule (sample 4) was free of acne bacteria in all patients treated with acne cream. In contrast, acne bacteria were found in the joint capsule in 4 of 19 untreated patients. In the subcutis (sample 3), 17 of 19 patients were free of acne bacteria, while only 6 out of 19 patients had no acne bacteria on the surface of the skin. If a comparison is performed between all participating patients, including those who had no acne bacteria on their skin in sample 1, the result is even clearer: acne bacteria was found in the joint capsule in 0 of 30 patients treated with the acne cream but in 5 patients who had not received the acne cream.

The Balgrist study also shows that acne bacteria in the joint capsule do not necessarily have to result in infections or inflammations. None of the patients, not even those with a positive acne bacteria result, had to be operated on again during the eleven-month follow-up period due to infections.

For first-time author Unterfrauner the most significant part of the study is the fact that, for the first time, the combined effect of the antibacterial substance benzoyl peroxide and the antifungal agent miconazole nitrate could be seen for the first time in operative procedures, as: “Studies with antibiotic treatment have not worked and antibiotics also have the disadvantage that they can develop resistance.”

Prof. Samy Bouaicha, who was responsible for running the study, referred to the practical benefit: “The pleasing results of our prospective study have led to our Shoulder Surgery team at Balgrist University Hospital routinely administering the acne cream for topical application on our patients a few days before planned surgical procedures.”

The study, which was published in the renowned Journal of Shoulder and Elbow Surgery in May 2022, has been awarded three prizes: the Neviaser Award for the best clinical paper from the Society of American Shoulder and Elbow Surgeons, the EFORT Free Paper Award Orthopedics for the best paper from the European Federation of National Associations of Orthopedics and Traumatology, and the Balgrist Research Award in Orthopedics for the best clinical paper from Balgrist University Hospital.

To the study

Contact for further information

Gregor Lüthy, Head of Corporate Communication
Balgrist University Hospital
+41 44 386 14 15
Email

The Ingenuity Lab will drive forward innovative research and development in the areas of materials, diagnostic equipment and therapeutic applications in the field of orthopedics. Among other things, the team is working on new tissue adhesive technologies for minimal-invasive and robot-supported surgery. Surgical adhesives with integrated sensors can be used to help detect infections and other complications in a timely manner. A further focus of the Ingenuity Lab is research into new treatment methods for radiation-resistant soft tissue tumors and anti-microbial resistance.

Under the leadership of Inge Herrmann, the research groups at the laboratory will work closely together with the clinical teams at Balgrist University Hospital to develop technology-based solutions that are customized to the biggest medical challenges. Inge Herrmann explained:

“Our vision at the Ingenuity Lab is to develop new solutions that are a direct response to the most urgent needs of the medical profession and patient care. We want to move the boundaries of medical technology. The combination of clinical excellence and innovative research is critical for developing the next generation of medical solutions. The Ingenuity Lab aims to exploit these synergies and offers a platform on which scientists, engineers and physicians can work together to design the medicine and medical technology of tomorrow.”

Balgrist University Hospital is known for its outstanding patient care and commitment to medical research and training. The opening of the Ingenuity Lab, just a few months after the OR-X, will further strengthen the hospital’s position as one of the leading centers for orthopedic research and treatment in Europe.

“We’re delighted to welcome Professor Herrmann and the Ingenuity Lab to Balgrist. This partnership underlines our commitment to innovation and excellence in orthopedics”, explained Professor Mazda Farshad, Medical Director of Balgrist University Hospital.

Contact for further information

Prof. Dr. Inge Herrmann
Balgrist University Hospital via Corporate Communication
+41 44 386 14 15
E-Mail

On 24 and 25 August, Balgrist University Hospital celebrated the opening of its tenth operating room (Operating Room X, in short: OR-X). Over 250 invited guests took the opportunity to visit the room with its modern technical equipment and listen to the speeches from Rita Fuhrer, President of the Balgrist Association, Mazda Farshad and Thomas Huggler, the Hospital Directors, Martin Hirzel, President of Swissmem, and Philipp Fürnstahl, one of the OR-X co-founders.

Yet patients will never see the new OR-X. It is a national research infrastructure and the surgical teaching and research center at Balgrist University Hospital. It combines a realistic infrastructure with the latest technology and is accessible to national and international experts. The heart of OR-X is a fully-equipped operating room that was designed for the surgical research and training of tomorrow. It’s a place where new technologies are developed, experienced surgeons receive further training and future surgeons are trained.

The X not only stands for the number 10, but also the great potential that this digitalized research infrastructure offers. Teaching is performed without any direct contact to patients and using 3D-printed models, simulators and human preparations. The direct integration into a clinic and the connection to the existing research environment is unique. The technical highlights include intraoperative artificial intelligence (AI), navigation systems, operating robots and applications supported by augmented reality (AR).

With its six surgical workstations, the Skills Lab provides the perfect conditions for conducting training and larger research experiments with several participants.

Contact for further information:

Prof. Dr. med. Mazda Farshad, Medical Director, Balgrist University Hospital
via Corporate Communication
Tel +41 44 386 14 15
E-Mail

In order to keep it as much instructive and interactive as possible, on-site places are restricted. As a novum, we outsourced the live streaming of the whole teaching course to the professional video and live streaming company yoveo, which makes the on-line participation also a very attractive option. There, we will again offer several interactive "ask the experts" sessions for the on-line participants during the on-site hands-on sessions.

Program

Course language
English

Venue
Balgrist University Hospital, Auditorium and seminar rooms
Forchstrasse 340, 8008 Zurich, Switzerland

Organizers
Dr. med Anne-Kathrin Peyer Kauffmann
Dr. med. David Lorenzana
Prof. Urs Eichenberger
Claudia Gasser-Fideeler, Chief Secretary
Department of Anaesthesia, Balgrist University Hospital

Faculty

• Dr. med Anne-Kathrin Peyer Kauffmann, neurolgist, Privat Practice in Liestal and University Hospital Basel, Switzerland
• Dr. med. David Lorenzana, anaesthesiologist, Head of Pain Medicine Department of Anaesthesia, Balgrist University Hospital, Switzerland
• Prof. Urs Eichenberger, anaesthesiologist, Head of Department of Anaesthesia, Intensive Care and Pain Medicine, Balgrist University Hospital, Switzerland
• Prof. Alexander Grimm, neurologist, University of Tübingen, Germany
• Prof. Einar Wilder-Smith, neurologist, Kantonsspital Lucerne, Switzerland
• Dr. med. Andras Schiller, neurologist, Privat Practice in Zürich, Switzerland
• PD Dr. med. Maria Teresa Pedro, neurosurgeon, University of Ulm, Günzburg, Germany
• Dr. med. Hannes Platzgummer, radiologist, University of Vienna, Austria
• Dr. med. Zsuzsanna Arányi, neurologist, Semmelweis University of Budapest, Hungary
• Dr. med. Christian Marx, rheumatologist, Privat Practice in Uster, Switzerland
• PD Dr. med. Florian Hatz, neurologist, University Hospital Basel, Switzerland
• Dr. med. Katrin Meyer, anaesthesiologist, Kantonsspital Lucerne, Switzerland
• Dr. med. Stephan Mittas, neurologist, Kantonsspital Lucerne, Switzerland
• PD Dr. med. Paolo Ripellino, neurologist, Ospedale Civico Lugano, Switzerland
• KD Dr. med. Giorgio Tamborrini, rheumatologist, Privat Practice in Basel and University Hospital Basel, Switzerland
• Prof. Dr. med. Esther Vögelin, handsurgeon, Inselspital Bern, Switzerland

Contact
Claudia Gasser
E-Mail

With this collaboration, Balgrist University Hospital in Zurich and Davos-based AO Foundation are strengthening preclinical, translational, and clinical research in musculoskeletal medicine. Together with the AO Research Institute, Davos (ARI), the development of innovative and novel treatment methods and implants is being advanced for the benefit of patients. Furthermore, the research projects have the potential to achieve additional advances in surgical education and training.

A complementary win-win situation for patients

AO Executive Director Research and Development and ARI Director Geoff Richards says: "ARI is a research institute with a fully focused multidisciplinary research team on one campus and one of the top in the world when it comes to disc degeneration and regeneration, infection, and musculoskeletal biomechanics – the topics of the joint PhDs. Similarly, Balgrist University Hospital and their research units are very strong in translational sciences. This collaboration is a win-win due to proximity and complement of knowledge within our areas."

Professor Mazda Farshad, MD, Medical Director of Balgrist University Hospital, says: "We focus on translational research. As a leading orthopedic university hospital with an integrated paraplegia center, our physician scientists identify the problems that remain unanswered for patients and answer them together with basic researchers and developers. This fits perfectly with the founding philosophy of the AO. The historically grown research and innovation focuses of Balgrist University Hospital and the AO complement each other, and, when combined, will make Switzerland the country with the highest impact on musculoskeletal medicine."

Two joint PhD projects in 2023

The collaboration has already begun and includes two jointly supervised PhD projects that start in 2023 focusing on research projects at ARI and Balgrist University Hospital. One of the projects is on functionalized annulus fibrosus repair patch to prevent post-surgical disc complication and the other is on patient-specific optimization of spinal fusions using validated computer simulations.

News AO-Foundation

AO Research Institute

For additional information please contact

via Franziska Ingold, Head of Corporate Communications, Balgrist University Hospital
+41 44 386 14 15
kommunikation@remove-this.balgrist.ch

via Olga Harrington, Head of Corporate Communications, AO Foundation
+41 79 834 57 42
communications@remove-this.aofoundation.org

Find out more:
www.balgrist.ch/spine

Prof. Dr. sc. Philipp Fürnstahl, principal investigator at Balgrist University Hospital, ex-plained the significance of «PROFICIENCY» for surgical training: «The use of artificial in-telligence and augmented reality heralds the dawn of a new era for highly specialized surgi-cal training. In just a few years, the first prototypes can be integrated into highly modern learning centers such as the OR-X at Balgrist University and made available to young sur-geons.»

Researchers and developers from Balgrist University Hospital and the Balgrist Campus have researched, developed and tested the surgical innovations behind «PROFICIENCY». These innovations stem from the SURGENT (Surgeon Enhancing Technologies) project and also forms the basis for the new, translational OR-X teaching and research center. The OR-X center is currently under construction and will be brought into operation at Balgrist University Hospital next year.

«PROFICIENCY» is a cooperation between Balgrist University Hospital, Zurich University, ETH Zurich, Cantonal Hospital of St. Gallen, the Centre hospitalier universitaire vaudois (CHUV), Zurich University of Applied Sciences (ZHAW) and the four companies VirtaMed AG, Microsoft Schweiz GmbH, ORamaVR S.A. and Atracsys LLC.

More Information
PROFICIENCY
Innosuisse

Contact for additional Information
Prof. Dr. sc. Philipp Fürnstahl, via Franziska Ingold, Head of Corporate Communications, Balgrist University Hospital
+41 44 386 14 15, kommunikation@remove-this.balgrist.ch

More Information

FAROS-Balgrist
FAROS-Website
 

Visit OR-X website

For further information, contact 
Prof. Dr. med. Mazda Farshad
Medical Director, Balgrist University Hospital

via Franziska Ingold
Head of Communications, Balgrist University Hospital
+41 44 386 14 15
Email

For further information, contact
Prof. Dr. med. Mazda Farshad, Medical Director, Balgrist University Hospital

Via Franziska Ingold, Head of Communications, Balgrist University Hospital
+41 44 386 14 15 / E-Mail

“A prominent milestone on the way towards orthopedics shaped by computer technology, with the goal of allowing fully digitalized treatment”, says Prof. Philipp Fürnstahl, Head of ROCS at Balgrist.

The study, which was approved by Swissmedic, is being carried out as part of Zurich University Medicine’s SURGENT (Surgeon Enhancing Technologies) Flagship Project. Together with their technology partner, Microsoft, Balgrist ROCS (Research in Orthopedic Computer Science) and Incremed, a university start-up supported by Balgrist Beteiligungs AG, are currently testing AR-based surgical navigation in orthopedics. “In orthopedics, augmented reality is the key to creating new standards for carrying out precise patient-specific surgery. Thanks to the cooperation between the Zurich University, the University hospitals and the ETH, Zurich is at the cutting edge globally,” says Prof. Dr. med. Mazda Farshad, Head of the Flagship Project and Chief Medical Officer of Balgrist University Hospital.

An important step for AR technology in the operating roomIn the first study of its type to be carried out anywhere in the world, complex surgical operations on the spine will be performed with or without holographic navigation, following a randomization procedure. The results of the initial phase are expected to be available in autumn 2020. A comparison of the groups should provide the basis for an important step towards bringing AR technology from the research laboratory into operating theatres across the world. Prof. Philipp Fürnstahl, Head of ROCS at Balgrist, sees it as “a prominent milestone on the way towards orthopedics shaped by computer technology, with the goal of allowing fully digitalized treatment.” And Marianne Janik, CEO of Microsoft Switzerland, adds “Cooperation with Balgrist University Hospital shows that augmented reality and artificial intelligence can already support and even enhance human abilities and expertise. We are proud that our technology meets the very high quality requirements and that we can contribute to this pioneering work.”
 

Benefits for patients
3D images of the affected anatomy are generated on the basis of CT scans and displayed directly in the surgical field during the operation. Surgeons can see the patient’s 3D anatomy using AR glasses. The AR navigation software guides each step of the operation. For example, it shows the exact placement of a screw at the correct site and the appropriate angle, and verifies the accuracy. In addition to the precise positioning of implant components, rod implants can be measured and thus individually dimensioned. This allows an enhancement of the surgeon’s perceptive senses.

For further information, contact
Franziska Ingold, Heas of Communications
Balgrist University Hospital
+41 44 386 14 15
Email

«The successful research project is an example of the interdisciplinary research activities at Balgrist University Hospital.»

A DFCI is usually an incidental finding on an MRI scan of the knee and often does not cause any symptoms. However, in the past such findings were often misinterpreted as tumors. The results of the study, which was published in the renowned journal Radiology, will considerably facilitate the diagnostic evaluation of such “pseudo-lesions”. In future, follow-up investigations and invasive bone biopsies will no longer be necessary. The successful research project is an example of the interdisciplinary research activities at Balgrist University Hospital, where researchers identify clinical problems in patients and translate them into corresponding scientific questions.

Distal femoral cortical irregularity (DFCI) on Knee MRI: Increased prevalence in youth
competitive alpine skiers. Stern C, Galley J, Fröhlich S, Peterhans L, Spörri J, Sutter R.
Radiology, 2020. [Epub before print] doi:10.1148/radiol.2020192589

Link to the study
 

For further information, contact
PD Dr. med. Reto Sutter, Chief of Radiology
via Franziska Ingold, Heas of Communications
Balgrist University Hospital
+41 44 386 14 15
Email

Seit elf Jahren ist Prof. Armin Curt Ordinarius für Paraplegiologie an der Universität Zürich und Chefarzt und Direktor des Zentrums für Paraplegie an der Universitätsklinik Balgrist. Er führt ausserdem die Forschergruppe für Paraplegie im Balgrist Campus. Das Team betreibt intensive Grundlagenforschung der Querschnittlähmung und des Rückenmarks. Curt misst der klinischen Forschung grosse Bedeutung zu und war massgeblich an den Forschungserfolgen seines Fachgebiets beteiligt. Gegenwärtig leitet er die europäische NISCI-Studie.

Nach dem Medizinstudium an der Universität Köln und der Ausbildung in Neurologie und klinischer Neurophysiologie begann er an der Universität Zürich seine Spezialisierung in der Versorgung und Rehabilitation von Rückenmarkverletzungen. Von 2005 bis 2008 war er ausserordentlicher Professor für Neurologie und SCI-Forschung an der University of British Columbia Vancouver, Kanada. Er ist Träger von zahlreichen nationalen und internationalen Stipendien, Ehrungen und Preisen. Seine primären Interessen sind translationale Forschung im menschlichen SCI, Neuro-Rehabilitation, klinische Neurophysiologie und Neuro-Imaging im menschlichen SCI.

Prof. Dr. med. Mazda Farshad: «Ich freue mich sehr, dass mit Prof. Dr. med. Armin Curt die Stellvertretung meiner Funktion als Medizinischer Direktor der Universitätsklinik Balgrist optimal sichergestellt ist. Die Zusammenarbeit mit ihm ist seit mehreren Jahren etabliert und im Rahmen des Universitären Wirbelsäulenzentrums Zürich noch weiter intensiviert worden.»

PD Dr. med. Patrick Zingg ist seit 2017 Leiter Hüft- und Beckenchirurgie und seit bald 20 Jahren an der Universitätsklinik Balgrist. Seine Spezialisierungen sind die gelenkserhaltende Chirurgie bei Impingement und bei Dysplasie (Hüftarthroskopie, periacetabuläre Beckenosteotomie, femorale Umstellungsosteotomie), die Prothetik (künstlicher Gelenksersatz) und die Revisionsprothetik (Prothesen-Wechsel, Rekonstruktion von Knochendefekten und Muskelschäden).

Prof. Jess Snedeker ist der Chief Scientific Officer des Balgirst Campus und seit bald 15 Jahren Leiter der Orthopädischen Biomechanik-Forschung an der Universitätsklinik Balgrist. Das Labor für Orthopädische Biomechanik ist eine multidisziplinäre Forschungseinheit, die sich wissenschaftlichen Fragen rund um den Bewegungsapparat widmet. Prof. Snedeker ist Inhaber eines gemeinsamen Lehrstuhls an der Universität Zürich und der ETH Zürich.

Prof. Dr. med. Mazda Farshad: «Es freut mich, dass mit der Beförderung von PD Dr. Patrick Zingg und Prof. Jess Snedeker die Stellvertretung meiner Funktion als Direktor Orthopädie hervorragend aufgestellt ist.»

2007 stiess Prof. Dr. med. Andreas Schweizer zur Universitätsklinik Balgrist. Mit innovativen Ideen hat er beträchtlich dazu beigetragen, die Handchirurgie an der Universitätsklinik Balgrist klinisch und akademisch voranzutreiben. Er gilt in seinem Fach als internatio-naler Experte und wird mit seinem Team das gesamte Spektrum der orthopädischen Handchirurgie sowie der peripheren Nervenchirurgie abdecken können.

Prof. Dr. med. Mazda Farshad, medizinischer Spitaldirektor der Universitätsklinik Balgrist, zum Wechsel in der Handchirurgie: «Ich freue mich, dass wir die Nachfolge der Leitung unserer Handchirurgie derart gezielt angehen konnten. Durch die interne Lösung ist die kontinuierliche Weiterentwicklung gewährleistet.»

Kontakte für weitere Informationen
Via Franziska Ingold, Leiterin Kommunikation
Universitätsklinik Balgrist
+41 44 386 14 15
E-Mail

Mit den eigenen 3D-Druckern werden ab sofort eigene Gesichtsschutze hergestellt. Die 3D-gedruckten Masken sind sterilisierbar und mit einer austauschbaren, sich nicht beschlagenden Spezialfolie versehen. Die ersten dieser Masken werden bereits in der Universitätsklinik Balgrist getestet und verwendet. Mit dieser Eigeninitiative leisten wir am Balgrist einen kleinen Beitrag zum Schutz des Spitalpersonals, das im Moment aussergewöhnliche Leistungen erbringt.

Hochpräzise Operationen dank Computertechnologie
Das ROCS ist ein interdisziplinäres und ambitioniertes Team aus Forschern, Ingenieuren und Chirurgen. Sie haben sich zum Ziel gesetzt, die Behandlung von Erkrankungen des Bewegungsapparates durch den Einsatz von Computertechnologie stetig zu verbessern. Zur ROCS-Forschungsgruppe gehört auch das Zentrum 3D-Planung und 3D-Druck der Universitätsklinik Balgrist, das die Chirurgen für schwierige orthopädische Operationen beiziehen können. Mit Hilfe von Computersimulation, Augmented Reality und 3D-Druck erarbeiten sie eine individuell auf den Patienten zugeschnittene Lösung und die Operation kann hochpräzise durchgeführt werden.
 

Kontakte für weitere Informationen
Prof. Dr. med. Mazda Farshad, Universitätsklinik Balgrist
Prof. Dr. Philipp Fürnstahl, Universitätsklinik Balgrist

Via Franziska Ingold, Leiterin Kommunikation
Universitätsklinik Balgrist
+41 44 386 14 15
E-Mail

Behandlung von komplexen orthopädischen und paraplegischen Fällen
Der Balgrist hat als Universitätsklinik einen universitären Versorgungsauftrag und führt nebst der hochspezialisierten Diagnostik auch die Behandlung von komplexen Fällen in den Fachbereichen Orthopädie und Paraplegie durch. Mit der neuen Intensivstation und des Aufwachraums stellen wir sicher, dass die Versorgung von komplexen Behandlungen und seltenen Erkrankungen weiterhin gewährleistet ist.

• Prof. Mazda Farshad, medizinischer Spitaldirektor: «Die Intensivstation ermöglicht die Behandlung aller orthopädischen Patienten, auch wenn es mal sehr kompliziert wird. Das differenziert die Universitätsklinik Balgrist als orthopädische Spezialklinik und erlaubt ihr die Tertiärversorgung.»

Auf der Intensivstation werden komplexe orthopädische Patientinnen und Patienten postoperativ intensivmedizinisch überwacht und gepflegt. Bei querschnittgelähmten Patienten stehen die Stabilisierung der lebenswichtigen Funktionen, die Prävention und Behandlung von Komplikationen, die Beatmung sowie die Schmerz- und Atemtherapie im Vordergrund.

Aktuell würden positiv auf das Coronavirus getestete Patienten isoliert und somit getrennt von orthopädischen oder paraplegischen Patienten behandelt. Damit kann die Universitätsklinik Balgrist das Gesundheitssystem tatkräftig unterstützen und mithelfen, den Ansturm auf die Akutspitäler zu entlasten.

Kontakt und Informationen
Kommunikation
+41 44 386 15 15
E-Mail

Telephone and video consultations
From now on, outpatients can communicate directly with their doctor by phone or by video, as a supplement to their regular appointments. Of course, we offer this option as a priority to particularly vulnerable patient groups. This emergency measure allows us to make an important contribution to the safety of our patients.

Please do not hesitate to contact the relevant secretary’s office if you have any questions or need any assistance.

Prof. Philipp Fürnstahl

Prof. Dr. med. Mazda Farshad: «Die Professur «Computer Science in orthopedics» will in enger Zusammenarbeit mit den Ärzten die Behandlung der Patienten verbessern. Dafür werden neuste Computertechnologien erforscht, entwickelt und eingesetzt. Wir freuen uns auf die Ausweitung dieser bereits erfolgreichen Forschungsgruppe.»
 

ROCS - Research in Orthopedic Computer Science
An der Universitätsklinik Balgrist betreibt ein interdisziplinäres und ambitioniertes Team aus Forschenden, Ingenieurinnen, Ingenieuren, Chirurginnen und Chirurgen Forschung in computerassistierter, orthopädischer Chirurgie. Das Ziel ist, die Behandlungsmethoden von Krankheiten am Bewegungsapparat durch den Einsatz von Computertechnologie stetig zu verbessern.

Durch die Schaffung der neuen Professur wird das Forschungsteam um Philipp Fürnstahl breiter aufgestellt und neu strukturiert. ROCS – Research Orthopedic Computer Science. Der interdisziplinäre Charakter zeichnet dieses Forschungsteam aus mit Grundlagenforschern der Computer Science und Mediziner.  Neben der Forschung wird ein Teil des Teams in Form des «Zentrums für 3D-Operationsplanung und 3D-Druck» für die Patientenbehandlung tätig sein und die Chirurgie mit Computermethoden bei komplexen orthopädischen Operationen unterstützen.

For the first time, it seems possible to improve the recovery of nerve function using a medication that also helps patients recover considerably better. The new antibodies, an endogenous inhibitor,(Nogo-A protein), which prevents growth and regeneration of nerve fibres, can be blocked in humans. The treatment aims to improve the regeneration and plasticity of the nerve fibres so that they can reunite. This should considerably improve both the motor and sensory functions and the patient’s quality of life.

This antibody therapy is currently being tested in a clinical trial that is being conducted across Europe, which is looking at patients in the first few weeks of an accident causing tetraplegia. Prof. Armin Curt, Director of the Spinal Cord injury Centre at Balgrist University Hospital, is coordinating the project.

For further information please contact

Balgrist University
Communications

+41 44 386 14 15

Focus on expansion of 3D planning methods

The new shoulder model developed by the researchers as part of the project, can be considered as one of the most comprehensive computer models for simulating patient-specific motions or bone and soft tissues pathologies. It includes three joints and 23 muscle components, including muscle fibres. In addition, the researchers were able to develop new methods for 3D planning and surgical navigation of tumour surgeries.

Great advances were also made in the surgical navigation of bone pathologies. Computer models combined with 3D printing allow highly accurate surgical planning tailored to the patient. The navigation system used is based on 3D-printed instruments that enable the surgeon to perform cutting and drilling highly accurate within millimeter accuracy. Clinical studies have shown that patients can be operated on more precisely, faster, and safer using these methods.

For further information please contact

Balgrist University Hospital 
Communications
+41 44 386 14 15